Detalles de la búsqueda
1.
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
Lancet
; 397(10282): 1351-1362, 2021 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33798499
2.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Lancet
; 398(10318): 2258-2276, 2021 12 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34863358
3.
Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess.
BMC Infect Dis
; 19(1): 490, 2019 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31159769
4.
Infectious causes of fever of unknown origin.
Clin Med (Lond)
; 15(3): 285-7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26031981
5.
Prospects for prevention of Salmonella infection in children through vaccination.
Curr Opin Infect Dis
; 26(3): 254-62, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23591641
6.
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
J Infect
; 87(1): 18-26, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085049
7.
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
Lancet Infect Dis
; 22(8): 1131-1141, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35550261
8.
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
J Infect
; 84(6): 795-813, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405168
9.
Clinical and Diagnostic Features of 413 Patients Treated for Imported Strongyloidiasis at the Hospital for Tropical Diseases, London.
Am J Trop Med Hyg
; 101(2): 428-431, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31219002
10.
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
J Infect
; 86(5): 540-541, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37055303
11.
Gastrointestinal symptoms in travellers.
Clin Med (Lond)
; 15(1): 93-5, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25650209
12.
Geographic, symptomatic and laboratory predictors of parasitic and bacterial causes of diarrhoea in travellers.
Trans R Soc Trop Med Hyg
; 106(9): 549-53, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22818743
13.
Cutaneous leishmaniasis acquired during a brief visit to Cyprus.
J Infect
; 70(3): 314-6, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25447711
Resultados
1 -
13
de 13
1
Próxima >
>>